← Leaderboards
April Pettit
Vanderbilt University
$5,162,754
Attributed
$10,079,911
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2013–25$2.5M$1.9M$1.3M$625K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
CDC$5,929,267 · 1
NIH$4,150,644 · 7
By mechanism
U01$5,929,267 · 1
R01$1,283,030 · 1
R33$1,232,752 · 1
R61$695,872 · 1
K08$541,028 · 1
P30$397,962 · 3
Top collaborators
- Carolyn Audet5 shared
- Meredith Reilly5 shared
- Tara Mckay3 shared
Most similar at Vanderbilt University
Same institution · by research overlap
- Tara McKay$6,907,571
- Michael S Pratte$936,877
Others in their field
Top investigators on “Persons”
- Wafaa M. El-Sadr · Columbia University Health Sciences$688,439,560
- Lawrence Corey · Fred Hutchinson Cancer Center$646,462,796
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- David R. Weir · University Of Michigan At Ann Arbor$386,183,647
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$377,922,183
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$265,384,316
Research focus
PersonsAcquired Immunodeficiency SyndromeFundingAffectPositioning AttributeUnited States National Institutes Of HealthIncidenceResearch PersonnelCommunitiesTennesseeResourcesBiometryClinical CareBehavioralCaringAwardSocialUnited StatesWorking GroupMentorsPublic HealthResearch DesignEpidemicEpidemiology
Grant awards (21)
Implementation of Rapid HIV Testing and Linkage to HIV Treatment or Prevention Among Vulnerable Populations in Tennessee$998,423
U01 · FY2025 · PS · contact PI
Evaluating the Clinical, Economic, and Social Impact of Evolving HIV Prevention and Care Strategies in Tennessee: A Multimethod Approach$612,327
R33 · FY2025 · MD · contact PI
Clinical Sciences Core (Core C)$297,166
P30 · FY2025 · AI · contact PI
Implementation of Rapid HIV Testing and Linkage to HIV Treatment or Prevention Among Vulnerable Populations in Tennessee$1,134,775
U01 · FY2024 · PS · contact PI
A Multimethod Assessment of the Clinical, Economic & Social Impact of the Rejection of Federal HIV Prevention Funds in Tennessee$620,425
R33 · FY2024 · MD · contact PI
Implementation of Rapid HIV Testing and Linkage to HIV Treatment or Prevention Among Vulnerable Populations in Tennessee$1,312,368
U01 · FY2023 · PS · contact PI
A Multimethod Assessment of the Clinical, Economic & Social Impact of the Rejection of Federal HIV Prevention Funds in Tennessee$695,872
R61 · FY2023 · MD · contact PI
Disparities in HIV Scientific Working Group$17,936
P30 · FY2023 · AI · contact PI
Implementation of Rapid HIV Testing and Linkage to HIV Treatment or Prevention Among Vulnerable Populations in Tennessee$1,358,764
U01 · FY2022 · PS · contact PI
Disparities in HIV Scientific Working Group$19,571
P30 · FY2022 · AI · contact PI
Implementation of Rapid HIV Testing and Linkage to HIV Treatment or Prevention Among Vulnerable Populations in Tennessee$1,124,937
U01 · FY2021 · PS · contact PI
Disparities in HIV Scientific Working Group$42,393
P30 · FY2021 · AI · contact PI
Multi-level Social and Behavioral Determinants of Health and Missed HIV Healthcare Provider Visits$388,719
R01 · FY2020 · MH · contact PI
Disparities in HIV Scientific Working Group$20,896
P30 · FY2020 · AI · contact PI
Multi-level Social and Behavioral Determinants of Health and Missed HIV Healthcare Provider Visits$388,719
R01 · FY2019 · MH · contact PI
Multi-level Social and Behavioral Determinants of Health and Missed HIV Healthcare Provider Visits$406,972
R01 · FY2018 · MH · contact PI
Multi-level Social and Behavioral Determinants of Health and Missed HIV Healthcare Provider Visits$98,620
R01 · FY2018 · MH · contact PI
Tuberculosis Risk and Highly Active Antiretroviral Therapy Initiation$135,257
K08 · FY2016 · AI · contact PI
Tuberculosis Risk and Highly Active Antiretroviral Therapy Initiation$135,257
K08 · FY2015 · AI · contact PI
Tuberculosis Risk and Highly Active Antiretroviral Therapy Initiation$135,257
K08 · FY2014 · AI · contact PI
Tuberculosis Risk and Highly Active Antiretroviral Therapy Initiation$135,257
K08 · FY2013 · AI · contact PI